Abstract
In 2004, Neuropeptide S (NPS) was identified to be the cognate ligand of the previously discovered orphan receptor GPCR 154, now termed as NPS receptor (NPSR). Since, then a wealth of data has elucidated the unique behavioral profile of this peptidergic system in numerous physiological function such as being pro-arousal and anxiolytic at the same time. Besides, its robust anxiolytic profile, this peptide system has been found to activate HPA axis and concomitant release of ACTH and corticosterone. Additionally, the involvement of NPS in reinstatement of drug seeking behavior has also been reported.
In recent years, accumulating data from various labs have demonstrated an A/T single-nucleotide polymorphism (SNP) resulting in (Asn107Ile) switch in the human NPSR gene as the risk factor for various psychiatric disorders such as panic disorder, post traumatic syndrome, alcohol use disorders and enhanced anxiety sensitivity, although, this is in stark contrast to the findings made in animal models which have consistently projected the anxiolytic nature of this peptide system. Therefore, in context of robust involvement of NPS system in various psychiatric disorders this review article considers the importance of NPS from translational point of view and appraises the need of therapies to be tailored around NPSR. In this respect, pharmacology of important NPSR ligands which have been recently developed has been discussed together with their possible side effects profile. Additionally, this review article encompasses all recent developments in the field of NPS system highlighting the role of this neuropeptide in all those biological functions which are modulated by this system. The role of this peptide has been discussed in detail in the perspective of sleep regulation, anxiety, fear expression and most importantly in drug addiction. Additionally, neuroimaging and genetic linkage studies addressing the functional impact of NPSR1 variants in the aforementioned psychiatric disorders have also been discussed.
Keywords: NPS, PD, anxiety, drug addiction, NPSR1, NPSR antagonist
Current Protein & Peptide Science
Title:The Physio-Pharmacological Role of the NPS/NPSR System in Psychiatric Disorders: A Translational Overview
Volume: 17 Issue: 4
Author(s): Pasha Ghazal
Affiliation:
Keywords: NPS, PD, anxiety, drug addiction, NPSR1, NPSR antagonist
Abstract: In 2004, Neuropeptide S (NPS) was identified to be the cognate ligand of the previously discovered orphan receptor GPCR 154, now termed as NPS receptor (NPSR). Since, then a wealth of data has elucidated the unique behavioral profile of this peptidergic system in numerous physiological function such as being pro-arousal and anxiolytic at the same time. Besides, its robust anxiolytic profile, this peptide system has been found to activate HPA axis and concomitant release of ACTH and corticosterone. Additionally, the involvement of NPS in reinstatement of drug seeking behavior has also been reported.
In recent years, accumulating data from various labs have demonstrated an A/T single-nucleotide polymorphism (SNP) resulting in (Asn107Ile) switch in the human NPSR gene as the risk factor for various psychiatric disorders such as panic disorder, post traumatic syndrome, alcohol use disorders and enhanced anxiety sensitivity, although, this is in stark contrast to the findings made in animal models which have consistently projected the anxiolytic nature of this peptide system. Therefore, in context of robust involvement of NPS system in various psychiatric disorders this review article considers the importance of NPS from translational point of view and appraises the need of therapies to be tailored around NPSR. In this respect, pharmacology of important NPSR ligands which have been recently developed has been discussed together with their possible side effects profile. Additionally, this review article encompasses all recent developments in the field of NPS system highlighting the role of this neuropeptide in all those biological functions which are modulated by this system. The role of this peptide has been discussed in detail in the perspective of sleep regulation, anxiety, fear expression and most importantly in drug addiction. Additionally, neuroimaging and genetic linkage studies addressing the functional impact of NPSR1 variants in the aforementioned psychiatric disorders have also been discussed.
Export Options
About this article
Cite this article as:
Ghazal Pasha, The Physio-Pharmacological Role of the NPS/NPSR System in Psychiatric Disorders: A Translational Overview, Current Protein & Peptide Science 2016; 17 (4) . https://dx.doi.org/10.2174/1389203717666151218150704
DOI https://dx.doi.org/10.2174/1389203717666151218150704 |
Print ISSN 1389-2037 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5550 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Dipeptidyl Peptidase-4 (CD26): Knowing the Function before Inhibiting the Enzyme
Current Medicinal Chemistry Discovery and Preliminary SAR of 5-Arylidene-2,2-Dimethyl-1,3-Dioxane- 4,6-Diones as Platelet Aggregation Inhibitors
Combinatorial Chemistry & High Throughput Screening Effect of Exchanged MgAl-Hydrotalcite with Carbonate on Increases of Acid Neutralizing Capacity: A Good Candidate as an Antacid
Current Nanomaterials Manipulation of the Immune System for Cancer Defeat: A Focus on the T Cell Inhibitory Checkpoint Molecules
Current Medicinal Chemistry Lysophospholipids: Their Generation, Physiological Role and Detection. Are They Important Disease Markers?
Mini-Reviews in Medicinal Chemistry Plasma Gelsolin: Function, Prognostic Value, and Potential Therapeutic Use
Current Protein & Peptide Science Analytical Methods for Determination of ·NO and ·NO2 and their Applicability in Biological Studies
Current Pharmaceutical Analysis Targeting 5-Lipoxygenase for Prevention and Treatment of Cancer
Current Enzyme Inhibition Monocyclic and Fused Azines and Azoles as Histamine H<sub>4</sub> Receptor Ligands
Current Medicinal Chemistry Selected Heterocyclic Compounds as Antioxidants. Synthesis and Biological Evaluation
Current Topics in Medicinal Chemistry Nonsteroidal Anti-Inflammatory Drugs: Exploiting Bivalent COXIB/ TP Antagonists for the Control of Cardiovascular Risk
Current Medicinal Chemistry The Human Microbiome Project, Personalized Medicine and the Birth of Pharmacomicrobiomics
Current Pharmacogenomics and Personalized Medicine Chymase as an Important Target for Preventing Complications of Metabolic Syndrome
Current Medicinal Chemistry Imaging of Spinal Bone Tumors: Principles and Practice
Current Medical Imaging Angiotensin Peptides as AT2 Receptor Agonists
Current Protein & Peptide Science Inhibitors of HMG-CoA Reductase: Current and Future Prospects
Mini-Reviews in Medicinal Chemistry Expressional Analysis and Role of Calcium Regulated Kinases in Abiotic Stress Signaling
Current Genomics Improved Anti-inflammatory Activity and Potential Cytoprotective Properties of Tolfenamic Acid, Naproxen and Indomethacin Derivatives
Letters in Drug Design & Discovery Antihistamine Use in Dermatologic Disorders
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Aurora Kinase Inhibitors in Head and Neck Cancer
Current Topics in Medicinal Chemistry